Advertisement

Topics

Puma Biotechnology, Inc. Company Profile

10:01 EDT 21st October 2017 | BioPortfolio

Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. The Company is initially focused on the development of PB-272 (oral neratinib), a potent irreversible tyrosine kinase inhibitor, for the treatment of patients with HER2 positive metastatic breast cancer.


News Articles [207 Associated News Articles listed on BioPortfolio]

Puma Biotechnology - Große Phantasie ist kurzfristig erstmal raus

Genauso wie Vertex ist auch Puma Biotechnology eine Beteiligung von BB Biotech, allerdings eine vergleichsweise kleine. Dennoch kann man sich darüber freuen, dass auch Puma zuletzt deutlich ansteig.....

BB Biotech: Mini-Beteiligung Puma Biotechnology gelingt der Durchbruch

Hinter Puma Biotechnology liegen bewegte Wochen. Das Brustkrebsmittel Neratinib der Firma war so gut wie abgeschrieben. Doch dann keimte Hoffnung auf: Die Zulassungsbehörde FDA empfahl in einem Gre.....

Puma purrs on FDA’s neratinib nod

The USA’s Puma Biotechnology was up by 9% at $93.68 in the opening moments of Tuesday’s trading after…

Breast cancer drug from Puma gets FDA approval

The FDA approved Puma Biotechnology's Nerlynx, or neratinib, as the first extended adjuvant treatment of early-stage HER2-pos -More- 

Victory for Puma as FDA approves breast cancer drug

The US regulator has approved Puma Biotechnology’s breast cancer drug, neratinib, in a use that reduces risk of the disease returning after initial treatment. Approval represents an against-the-odd...

Expecting More Fireworks in Puma Biotechnology Stock

PBYI Stock: Setting up to Stage an Advance Puma Biotechnology Inc (NYSE:PBYI) stock staged quite an advance in May 2017 as investors' concerns about poor earnings results were cast away after some .....

Puma Biotechnology Presents 5-Year Analysis of Phase III ExteNET Trial in Extended Adjuvant HER2-Positive Breast Cancer at ESMO 2017 Congress

Friday, September 8th 2017 at 1:03pm UTC Data Demonstrates Continued Benefit from Neratinib after 5 years LOS ANGELES–(BUSINESS WIRE)– Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmac...

US OK’s Puma’s new breast cancer therapy

Puma Biotechnology’s experimental breast cancer therapy Nerlynx has been issued a green light by the US Food and Drug Administration.

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Korres quercetin 7 oak hydrating antiageing and antiwrinkle [Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc.]

Korres Quercetin & Oak Day Cream for Normal to Dry Skin SPF 4

Bio-active anti-aging [S.I.P.R.E.S. SRL]

Bio-Active Anti-Aging Cream Multi-Protection Daily Renewal SPF 15 Advanced Double Lifting Effect

Biodynamic skin [S.I.P.R.E.S. SRL]

Biodynamic Skin Solution

PubMed Articles [340 Associated PubMed Articles listed on BioPortfolio]

Platform for Unified Molecular Analysis: PUMA.

We introduce a free platform for chemoinformatic-based diversity analysis and visualization of chemical space of user supplied data sets. Platform for Unified Molecular Analysis (PUMA) integrates metr...

Targeting the apoptotic Mcl-1-PUMA interface with a dual-acting compound.

Despite intensive efforts in the search for small molecules with anti-cancer activity, it remains challenging to achieve both high effectiveness and safety, since many agents lack the selectivity to o...

Clinical significance and expression of PUMA, MCL-1, and p53 in human renal cell carcinoma and para-carcinoma tissues.

We investigated the expression level of p53 upregulated modulator of apoptosis (PUMA), myeloid cell leukemia-I (MCL-1), and p53 in renal cell carcinoma (RCC) and para-carcinoma tissues, as well as the...

The muscle regulatory transcription factor MyoD participates with p53 to directly increase the expression of the pro-apoptotic Bcl2 family member PUMA.

The muscle regulatory transcription factor MyoD is a master regulator of skeletal myoblast differentiation. We have previously reported that MyoD is also necessary for the elevated expression of the p...

Cyclic AMP-Epac signaling pathway contributes to repression of PUMA transcription in melanoma cells.

The universal second messenger cAMP regulates numerous cellular processes. Although the cAMP-signaling pathway leads to induction of gene transcription, it remains unknown whether this pathway contrib...

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors

In the laboratory, Kevetrin activates p53, a tumor suppressor protein that has an important role in protecting the body. p53 functions by activating proteins that repair DNA and kill cells...

A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

In order to evaluate immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine produced by Beijing Minhai Biotechnology Co., Ltd., a randomized, double-blind, parallel-contro...

RESULT: Reliable, Emergent Solution Using Liprotamase Treatment

Liprotamase powder is a non-porcine, soluble and stable mixture of biotechnology-derived lipase, protease, and amylase digestive enzymes. The purpose of the present study is to to evaluate...

Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old

This study will be a Phase I, randomized, double blind, safety and immunogenicity trial of the Vero cell based 116E neonatal rotavirus vaccine candidate strain in healthy non-malnourished ...

Companies [855 Associated Companies listed on BioPortfolio]

Puma Biotechnology, Inc.

Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company ...

PUMA

Task Group Public Perceptions of Biotechnology

The Task Group on Public Perceptions of Biotechnology is one of the six Task Groups of the European Federation of Biotechnology. It was established in 1991, to increase public awareness and understand...

Missouri Biotechnology Association

The Missouri Biotechnology Association is focused on maintaining the growth of the biotechnology industry generated by the research and development communities of Missouri. While we have made great st...

Bioteknologinemnda

The Norwegian Biotechnology Advisory BoardThe Norwegian Biotechnology Advisory Board is an independent body consisting of 24 members appointed by the Norwegian government. Each member has a background...

More Information about "Puma Biotechnology, Inc." on BioPortfolio

We have published hundreds of Puma Biotechnology, Inc. news stories on BioPortfolio along with dozens of Puma Biotechnology, Inc. Clinical Trials and PubMed Articles about Puma Biotechnology, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Puma Biotechnology, Inc. Companies in our database. You can also find out about relevant Puma Biotechnology, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record